TY - JOUR
T1 - Pre-pregnancy endothelial dysfunction and birth outcomes
T2 - The Coronary Artery Risk Development in Young Adults (CARDIA) Study article
AU - Lane-Cordova, Abbi D.
AU - Gunderson, Erica P.
AU - Carnethon, Mercedes R.
AU - Catov, Janet M.
AU - Reiner, Alex P.
AU - Lewis, Cora E.
AU - Dude, Annie M.
AU - Greenland, Philip
AU - Jacobs, David R.
N1 - Funding Information:
Funding CARDIA is supported by the National Heart, Lung, and Blood Institute (NHLBI) HHSN 268201300025C, HHSN 268201300026C, HHSN 268201300027C, HHSN 268201300028C, HHSN 268201300029C, HHSN 268200900041C, and partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). Cellular adhesion molecules were measured using funds from R01 HL 053560 and R01 HL093077 (Jacobs and Gross, PIs). The analyses were supported by grants from R01 DK106201 (Gun-derson, PI), R01 DK090047 (Gunderson, PI), and K01 DK059944 (Gunderson, PI) from the National Institute of Diabetes, Digestive and Kidney Diseases. ALC is supported by an American Heart Association Strategically Focused Research Network Grant 14SFRN20480260 (Greenland, PI). This manuscript was reviewed by CARDIA for scientific content.
Publisher Copyright:
© 2018 The Japanese Society of Hypertension.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Endothelial dysfunction is a form of subclinical cardiovascular disease that may be involved in preterm birth and small-for-gestational-age deliveries. However, concentrations of biomarkers of endothelial dysfunction before pregnancy have rarely been measured. We hypothesized that higher levels of biomarkers of endothelial dysfunction (cellular adhesion molecules and selectins) would be associated with odds of preterm birth and/or small-for-gestational-age deliveries. We included 235 women from the Coronary Artery Risk Development in Young Adults (CARDIA) study who were nulliparous at Y7, reported ≥1 live birth through Y25, and had ≥1 biomarker measured at Y7. We tested for associations between individual biomarkers and an averaged z-score representing total endothelial dysfunction with preterm birth and/or small-for-gestational-age deliveries using Poisson regression, adjusted for demographic and clinical characteristics at the exam immediately preceding index birth. At Y7, total evidence of endothelial dysfunction was similar in women who did (n = 59) and did not have (n = 176) preterm birth and/or small-for-gestational-age deliveries. There was no association between biomarkers of endothelial dysfunction (either individual biomarker or total score) with odds of preterm birth and/or small-for-gestational-age deliveries after adjustment: IRR = 1.01, 95% CI: 0.74, 1.39, p = 0.93 for total endothelial biomarker score. Associations were not modified by race. We conclude that biomarkers of endothelial dysfunction in nulliparous women, measured ~3 years before pregnancy, did not identify women at risk for preterm birth and/or small-for-gestational-age deliveries. This suggests that the maternal endothelial dysfunction that is believed to contribute to these birth outcomes may not be detectable before pregnancy.
AB - Endothelial dysfunction is a form of subclinical cardiovascular disease that may be involved in preterm birth and small-for-gestational-age deliveries. However, concentrations of biomarkers of endothelial dysfunction before pregnancy have rarely been measured. We hypothesized that higher levels of biomarkers of endothelial dysfunction (cellular adhesion molecules and selectins) would be associated with odds of preterm birth and/or small-for-gestational-age deliveries. We included 235 women from the Coronary Artery Risk Development in Young Adults (CARDIA) study who were nulliparous at Y7, reported ≥1 live birth through Y25, and had ≥1 biomarker measured at Y7. We tested for associations between individual biomarkers and an averaged z-score representing total endothelial dysfunction with preterm birth and/or small-for-gestational-age deliveries using Poisson regression, adjusted for demographic and clinical characteristics at the exam immediately preceding index birth. At Y7, total evidence of endothelial dysfunction was similar in women who did (n = 59) and did not have (n = 176) preterm birth and/or small-for-gestational-age deliveries. There was no association between biomarkers of endothelial dysfunction (either individual biomarker or total score) with odds of preterm birth and/or small-for-gestational-age deliveries after adjustment: IRR = 1.01, 95% CI: 0.74, 1.39, p = 0.93 for total endothelial biomarker score. Associations were not modified by race. We conclude that biomarkers of endothelial dysfunction in nulliparous women, measured ~3 years before pregnancy, did not identify women at risk for preterm birth and/or small-for-gestational-age deliveries. This suggests that the maternal endothelial dysfunction that is believed to contribute to these birth outcomes may not be detectable before pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=85042081664&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042081664&partnerID=8YFLogxK
U2 - 10.1038/s41440-018-0017-5
DO - 10.1038/s41440-018-0017-5
M3 - Article
C2 - 29449706
AN - SCOPUS:85042081664
SN - 0916-9636
VL - 41
SP - 282
EP - 289
JO - Hypertension Research
JF - Hypertension Research
IS - 4
ER -